Molecular and functional characterization of a human frataxin mutation found in hypertrophic cardiomyopathy

Sara L. Van Driest, Oleksandr Gakh, Steve R. Ommen, Grazia Isaya, Michael John Ackerman

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Hypertrophic cardiomyopathy is associated with marked genetic and phenotypic heterogeneity. Pathogenic mutations in the 10 hypertrophic cardiomyopathy-associated sarcomeric genes cause autosomal dominant disease as a rule, although recessive disease has been reported. Cardiac hypertrophy is also a hallmark of Friedreich ataxia, an autosomal recessive disease caused by deficiency of the mitochondrial protein frataxin. We hypothesized that heterozygous mutations in frataxin may mimic or modify hypertrophic cardiomyopathy. Using DHPLC and DNA sequencing, we identified the novel R40C-frataxin mutation in a patient who also harbored a previously reported R810H-myosin binding protein C mutation. The R810H mutation is reported to cause hypertrophic cardiomyopathy only in the setting of homozygosity or compound heterozygosity with another sarcomeric mutation. Site-directed mutagenesis and in vitro and in vivo analysis enabled functional characterization of the mutant frataxin protein. R40C-frataxin protein is not cleaved to the mature form in vitro and shows delayed kinetics of cleavage by isolated mouse mitochondria. Yeast cells expressing R40C-frataxin demonstrated increased sensitivity to oxidative stress and abnormal accumulation of precursor frataxin protein. These data indicate that frataxin deficiency may have contributed to this patient's particular phenotype. Furthermore, these findings suggest that mutations altering myocyte energetics may act in synergy with sarcomeric mutations to cause hypertrophic cardiomyopathy.

Original languageEnglish (US)
Pages (from-to)280-285
Number of pages6
JournalMolecular Genetics and Metabolism
Volume85
Issue number4
DOIs
StatePublished - Aug 2005

Fingerprint

Hypertrophic Cardiomyopathy
Mutation
Friedreich Ataxia
Deficiency Diseases
Mutagenesis
Functional analysis
Proteins
Mitochondria
Oxidative stress
Protein Precursors
Genetic Heterogeneity
frataxin
Mitochondrial Proteins
Cardiomegaly
Mutant Proteins
Site-Directed Mutagenesis
DNA Sequence Analysis
Yeast
Muscle Cells
Oxidative Stress

Keywords

  • Frataxin
  • Friedreich ataxia
  • Genetics
  • Hypertrophic cardiomyopathy
  • Myosin binding protein C

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this

Molecular and functional characterization of a human frataxin mutation found in hypertrophic cardiomyopathy. / Van Driest, Sara L.; Gakh, Oleksandr; Ommen, Steve R.; Isaya, Grazia; Ackerman, Michael John.

In: Molecular Genetics and Metabolism, Vol. 85, No. 4, 08.2005, p. 280-285.

Research output: Contribution to journalArticle

Van Driest, Sara L. ; Gakh, Oleksandr ; Ommen, Steve R. ; Isaya, Grazia ; Ackerman, Michael John. / Molecular and functional characterization of a human frataxin mutation found in hypertrophic cardiomyopathy. In: Molecular Genetics and Metabolism. 2005 ; Vol. 85, No. 4. pp. 280-285.
@article{c576f6a054864794b148d80a555f7e90,
title = "Molecular and functional characterization of a human frataxin mutation found in hypertrophic cardiomyopathy",
abstract = "Hypertrophic cardiomyopathy is associated with marked genetic and phenotypic heterogeneity. Pathogenic mutations in the 10 hypertrophic cardiomyopathy-associated sarcomeric genes cause autosomal dominant disease as a rule, although recessive disease has been reported. Cardiac hypertrophy is also a hallmark of Friedreich ataxia, an autosomal recessive disease caused by deficiency of the mitochondrial protein frataxin. We hypothesized that heterozygous mutations in frataxin may mimic or modify hypertrophic cardiomyopathy. Using DHPLC and DNA sequencing, we identified the novel R40C-frataxin mutation in a patient who also harbored a previously reported R810H-myosin binding protein C mutation. The R810H mutation is reported to cause hypertrophic cardiomyopathy only in the setting of homozygosity or compound heterozygosity with another sarcomeric mutation. Site-directed mutagenesis and in vitro and in vivo analysis enabled functional characterization of the mutant frataxin protein. R40C-frataxin protein is not cleaved to the mature form in vitro and shows delayed kinetics of cleavage by isolated mouse mitochondria. Yeast cells expressing R40C-frataxin demonstrated increased sensitivity to oxidative stress and abnormal accumulation of precursor frataxin protein. These data indicate that frataxin deficiency may have contributed to this patient's particular phenotype. Furthermore, these findings suggest that mutations altering myocyte energetics may act in synergy with sarcomeric mutations to cause hypertrophic cardiomyopathy.",
keywords = "Frataxin, Friedreich ataxia, Genetics, Hypertrophic cardiomyopathy, Myosin binding protein C",
author = "{Van Driest}, {Sara L.} and Oleksandr Gakh and Ommen, {Steve R.} and Grazia Isaya and Ackerman, {Michael John}",
year = "2005",
month = "8",
doi = "10.1016/j.ymgme.2005.04.010",
language = "English (US)",
volume = "85",
pages = "280--285",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Molecular and functional characterization of a human frataxin mutation found in hypertrophic cardiomyopathy

AU - Van Driest, Sara L.

AU - Gakh, Oleksandr

AU - Ommen, Steve R.

AU - Isaya, Grazia

AU - Ackerman, Michael John

PY - 2005/8

Y1 - 2005/8

N2 - Hypertrophic cardiomyopathy is associated with marked genetic and phenotypic heterogeneity. Pathogenic mutations in the 10 hypertrophic cardiomyopathy-associated sarcomeric genes cause autosomal dominant disease as a rule, although recessive disease has been reported. Cardiac hypertrophy is also a hallmark of Friedreich ataxia, an autosomal recessive disease caused by deficiency of the mitochondrial protein frataxin. We hypothesized that heterozygous mutations in frataxin may mimic or modify hypertrophic cardiomyopathy. Using DHPLC and DNA sequencing, we identified the novel R40C-frataxin mutation in a patient who also harbored a previously reported R810H-myosin binding protein C mutation. The R810H mutation is reported to cause hypertrophic cardiomyopathy only in the setting of homozygosity or compound heterozygosity with another sarcomeric mutation. Site-directed mutagenesis and in vitro and in vivo analysis enabled functional characterization of the mutant frataxin protein. R40C-frataxin protein is not cleaved to the mature form in vitro and shows delayed kinetics of cleavage by isolated mouse mitochondria. Yeast cells expressing R40C-frataxin demonstrated increased sensitivity to oxidative stress and abnormal accumulation of precursor frataxin protein. These data indicate that frataxin deficiency may have contributed to this patient's particular phenotype. Furthermore, these findings suggest that mutations altering myocyte energetics may act in synergy with sarcomeric mutations to cause hypertrophic cardiomyopathy.

AB - Hypertrophic cardiomyopathy is associated with marked genetic and phenotypic heterogeneity. Pathogenic mutations in the 10 hypertrophic cardiomyopathy-associated sarcomeric genes cause autosomal dominant disease as a rule, although recessive disease has been reported. Cardiac hypertrophy is also a hallmark of Friedreich ataxia, an autosomal recessive disease caused by deficiency of the mitochondrial protein frataxin. We hypothesized that heterozygous mutations in frataxin may mimic or modify hypertrophic cardiomyopathy. Using DHPLC and DNA sequencing, we identified the novel R40C-frataxin mutation in a patient who also harbored a previously reported R810H-myosin binding protein C mutation. The R810H mutation is reported to cause hypertrophic cardiomyopathy only in the setting of homozygosity or compound heterozygosity with another sarcomeric mutation. Site-directed mutagenesis and in vitro and in vivo analysis enabled functional characterization of the mutant frataxin protein. R40C-frataxin protein is not cleaved to the mature form in vitro and shows delayed kinetics of cleavage by isolated mouse mitochondria. Yeast cells expressing R40C-frataxin demonstrated increased sensitivity to oxidative stress and abnormal accumulation of precursor frataxin protein. These data indicate that frataxin deficiency may have contributed to this patient's particular phenotype. Furthermore, these findings suggest that mutations altering myocyte energetics may act in synergy with sarcomeric mutations to cause hypertrophic cardiomyopathy.

KW - Frataxin

KW - Friedreich ataxia

KW - Genetics

KW - Hypertrophic cardiomyopathy

KW - Myosin binding protein C

UR - http://www.scopus.com/inward/record.url?scp=23044505674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044505674&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2005.04.010

DO - 10.1016/j.ymgme.2005.04.010

M3 - Article

C2 - 15936968

AN - SCOPUS:23044505674

VL - 85

SP - 280

EP - 285

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 4

ER -